By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novira Therapeutics 

Philadelphia  Pennsylvania    U.S.A.
Phone: n/a Fax: n/a



Life Sciences

Company News
Novira Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference In San Francisco 1/9/2015 7:51:38 AM
Novira Therapeutics Announces Appointment Of Brian F. Daniels, M.D., To Its Scientific Advisory Board 11/18/2014 1:41:53 PM
Novira Therapeutics Announces Presentation Of Phase 1a Safety And Pharmacokinetic Data For NVR 3-778 11/10/2014 8:53:55 AM
Novira Therapeutics Announces Successful Completion Of Phase 1a Clinical Study Of NVR-1221 And Commencement Of Phase 1b Clinical Studies 9/4/2014 11:13:29 AM
Novira Therapeutics Announces Appointment Of Roger J. Pomerantz, M.D., F.A.C.P., As Chair Of Scientific Advisory Board 8/26/2014 9:07:32 AM
Novira Therapeutics Begins Phase 1a Clinical Study Of NVR-1221 For The Treatment Of Chronic Hepatitis B (HBV) Infection 5/8/2014 9:13:39 AM
Novira Therapeutics Names Christian S. Schade Chief Executive Officer 3/19/2014 6:56:23 AM
Novira Therapeutics Expands Management Team with Appointment of Klaus Klumpp, Ph.D., the Former Global Head of Roche's Virology Discovery Initiatives, as Vice President Discovery Research 6/5/2013 9:24:57 AM
Novira Therapeutics Completes $25 Million Series A Financing 3/25/2013 6:42:30 AM
Novira Therapeutics Secures $23 Million Series A Financing to Advance Antiviral Research 8/24/2012 6:50:57 AM